BridgeBio Pharma Proclaims Founding Affiliation with Bakar Labs, Incubator at UC Berkeley’s Bakar BioEnginuity Hub
[ad_1] PALO ALTO, Calif., July 21, 2022 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical firm targeted on genetic illnesses and cancers, immediately introduced its founding affiliation with Bakar Labs, the incubator at UC Berkeley’s Bakar BioEnginuity Hub. Bakar Labs was established by the College of California (UC), Berkeley and QB3, UC’s analysis … Read more